The CBMTS IV
Spiez Laboratory Switzerland
28 April - 3 May 2002
Symposium Chair Dr. Barbara Price's concluding remarks:
of you for attending the CBMTS IV. We have had 28 countries represented
here discussing chemical and biological medical treatment. In the first
CBMTS in 1994 we were still listening to papers addressing measurements
of LD50 for CW agents and summaries of how antidotes and
oxime treatments worked and characterizing viruses and looking at general
response type biodetectors.
later, we really have come a long way. We are addressing much more complicated
medical treatments, refining these treatments, using much more sophisticated
instrumentation and really examining the effects of different cell infections
on the viruses and the proteins they express. And we, the 140 CBMTS
IV professionals, have had many discussions on bioterrorism.
we get the criticism that an author is presenting older work with just
a little bit of new material added. This has happened, but even then
we have also received comments saying that "I'm new to the field and
now I finally understand why that technique is important." The CBMTS
offers scientists the chance to talk to each other, not just to listen
to papers. It is an excellent opportunity to walk up to another scientist
to say, "I'm not sure I fully understand the point of your experiments
here, would you please explain why you did thus and such."
has always mixed bio and chem. And offered us all the chance to learn
about both fields. And now we are really combining these fields in our
incidence and consequence management approaches.
CBMTS's real successes have been:
- Better cooperation and collaboration between countries and agencies
- Standardization of AChE measurements around the world to the point
that a commercialized product and method is now available. This was
spearheaded by Dr. Rudolf Portmann and Dr. Ladislaus Scinicz.
- Closer examination of sodium bicarbonate in OP poisoning treatment.
This concept was first introduced by Dr. Balali-Mood and it is wonderful
to see how other medical doctors have not dismissed it, but have gathered
together to investigate how it works because it offers poorer countries
a more affordable medical treatment of OP poisoning victims.
- Sharing of their database of medical treatment of CW casualties
in Iran by the Iranian doctors.
- Looking at an international network of infectious disease centers
to expedite communication and treatment of disease outbreaks.
- Information and contacts for scientists, doctors, and policy makers
in all countries.
- And finally, discussions of what worked and did not work in various
natural disasters, terrorist acts and industrial accidents, which
have helped all of us to refine our response plans.
us at the CBMTS are to be commended for our commitment to international
cooperation in treatment aspects of chemical and biological agents.
We really have brought hope for the future in this field.
Barbara Price Ph.D.
Chair CBMTS IV
Battelle Memorial Institute